Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Other Non Operating Income data on file, last reported at $35000.0 in Q1 2026.

• Quarterly Other Non Operating Income rose 266.67% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (down 46.18% YoY) and the FY2025 annual result came in at $382000.0, down 97.49% from the prior year.
• Other Non Operating Income fell to $35000.0 in Q1 2026, from $701000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $34.0 million in Q1 2023 to a low of -$34.2 million in Q4 2023.
• A 5-year average of $456294.1 and a median of $4000.0 in 2023 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2023 — Other Non Operating Income jumped 6120.04% — and 2024, when it tumbled 5125.0%.
• Tracing ARCT's Other Non Operating Income over 5 years: stood at -$3.8 million in 2022, then plunged by 791.32% to -$34.2 million in 2023, then surged by 109.4% to $3.2 million in 2024, then tumbled by 78.19% to $701000.0 in 2025, then plunged by 95.01% to $35000.0 in 2026.
• The last three Other Non Operating Income figures came in at $35000.0 (Q1 2026), $701000.0 (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.